4//SEC Filing
Renstrup Jens 4
Accession 0001104659-21-002795
CIK 0001773427other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 9:30 AM ET
Size
7.3 KB
Accession
0001104659-21-002795
Insider Transaction Report
Form 4
Renstrup Jens
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-01-07+48,600→ 48,600 totalExercise: $70.68Exp: 2031-01-07→ Common Stock (48,600 underlying) - Award
Common Stock
2021-01-07+6,075→ 250,499 total
Footnotes (2)
- [F1]Represents restricted stock awards. The restricted stock awards shall vest as follows: thirty three percent (33%) to vest on January 7, 2022, another thirty three percent (33%) to vest on January 7, 2023 and the remaining thirty four percent (34%) to vest on January 7, 2024, such that the restricted stock awards are fully vested on January 7, 2024.
- [F2]svThis option shall vest in 48 equal monthly installments subject to continued service to the Company by the Reporting Person.
Documents
Issuer
SpringWorks Therapeutics, Inc.
CIK 0001773427
Entity typeother
Related Parties
1- filerCIK 0001786967
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 9:30 AM ET
- Size
- 7.3 KB